Table of Contents
<< Previous Issue | Jun 2008 (Vol: 2008, Issue: 97) | Next Issue >> |
- Section: Business Commentaries
-
June Gloom?
- Section: Licensing
-
Roche Gains Novel Anticancer Antibody Product
- Section: Mergers & Acquisitions
-
Novartis Gains MRSA Product Through Acquisition of Protez Pharmaceuticals
-
Ipsen Expands Existing US Base through Acquisitions Worth $458 Million
-
Daiichi Sankyo Diversifies into Generics through Major Investment in Indian Giant
-
Boehringer Ingelheim’s Structured Venture into Biotech
- Section: Research & Development
-
GlaxoSmithKline Boosts its Infectious Disease Portfolio